Search by Drug Name or NDC
NDC 67457-0994-05 Regadenoson 0.4 mg/5mL Details
Regadenoson 0.4 mg/5mL
Regadenoson is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is REGADENOSON.
Product Information
| NDC | 67457-0994 |
|---|---|
| Product ID | 67457-994_e1ab38bf-cfd0-444f-a8a6-bb8588b63228 |
| Associated GPIs | |
| GCN Sequence Number | 064044 |
| GCN Sequence Number Description | regadenoson SYRINGE 0.4 MG/5ML INTRAVEN |
| HIC3 | A6V |
| HIC3 Description | CARDIOVASCULAR DIAGNOSTICS,NON-RADIOPAQUE AGENTS |
| GCN | 99755 |
| HICL Sequence Number | 035625 |
| HICL Sequence Number Description | REGADENOSON |
| Brand/Generic | Generic |
| Proprietary Name | Regadenoson |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Regadenoson |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.4 |
| Active Ingredient Units | mg/5mL |
| Substance Name | REGADENOSON |
| Labeler Name | Mylan Institutional LLC |
| Pharmaceutical Class | Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213856 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 67457-0994-05 (67457099405)
| NDC Package Code | 67457-994-05 |
|---|---|
| Billing NDC | 67457099405 |
| Package | 1 SYRINGE in 1 CARTON (67457-994-05) / 5 mL in 1 SYRINGE |
| Marketing Start Date | 2023-09-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |